South Korea
South Korean Firm Lunit Raises $150 Million in Capital Boost
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the successful completion ...
November 16, 2023 | News
Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT market
Lunit a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced that it has received U.S. Food and Dr...
November 15, 2023 | News
Guardant Health Introduces Shield Blood Test for Colorectal Cancer in South Korea
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and the third-leading cause of cancer-related deaths in South Korea.1,2 Gua...
November 13, 2023 | News
PharmAbcine Advances PMC-403 Clinical Trial in South Korea for Macular Degeneration
Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the higher dose treatment. The starting dose (0.7m...
November 10, 2023 | News
GC Biopharma Seeks South Korean MFDS Approval for World's First Recombinant Anthrax Vaccine.
'GC1109' contains protective antigen (PA) as its active pharmaceutical ingredients produced by recombinant DNA technology which delivers 2 types of protein...
November 06, 2023 | News
Curocell Completes Korea's First Phase 2 Clinical Trial for Next-Generation CAR-T
Anbal-cel argeting DLBCL completes phase 2 trial Anticipation growing over Korea's first CAR-T therapy ahead of regulatory review Commerci...
November 02, 2023 | News
Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced a research collaboration with The ...
October 30, 2023 | News
Samsung Biologics and Kurma Partners Forge Biologics Development & Manufacturing Alliance for Kurma's Portfolio
- Samsung Biologics to provide de-risking, development, manufacturing services, and seamless transitions for biologics from early stages of developmen...
October 25, 2023 | News
VUNO Secures FDA 510(k) Clearance for VUNO Med®-DeepBrain®
VUNO Med®-DeepBrain® is intended to automate the current manual process of identifying, labeling, and quantifying segmentable brain structures from...
October 24, 2023 | News
Seegene Strengthens ESG Commitment with 100% Recyclable, Styrofoam-Free Shipping Boxes in South Korea
100% recyclable package made with eco-friendly and FSC-certified materials to proactively meet evolving global environmental regulations Patent des...
October 19, 2023 | News
ABL Bio Achieves Regulatory Clearance for Innovative Bispecific Antibody in Solid Tumor; GenScript ProBio Commends Milestone Collaboration
ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...
October 13, 2023 | News
Specialised Therapeutics Secures Exclusive License for Novel Ovarian Cancer Treatment from CanariaBio
First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progress...
October 13, 2023 | News
HanAll, Daewoong, and NurrOn Launch Phase 1 Study for HL192
HanAll Biopharma and Daewoong Pharmaceutical marked a pivotal step forward in the development of HL192 (ATH-399A) for the potential treatment of Parkinso...
October 13, 2023 | News
CanariaBio and Hikma Sign Oregovomab Distribution and License Deal for MENA Region
"We are thrilled to partner with Hikma, a company with a strong presence in the MENA region and a proven track record of successful collaborations," said&n...
October 11, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
